18
Mar 2026
A team led by La Trobe University has drawn inspiration from nature to develop a breakthrough sensor that can rapidly track tiny molecular changes in blood, paving the way to real-time, personalized medicine.
18
Mar 2026
A research group led by Professor Cecilia Sahlgren at Åbo Akademi University (Finland) and the InFLAMES Research Flagship has identified a new mechanism directing the adverse remodeling of tumor tissue during breast cancer progression.
18
Mar 2026
Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments, now in clinical trials, that target the whole protein but leave this fragment intact, a new study in mice suggests.
18
Mar 2026
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits.
18
Mar 2026
Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors use this nutrient.
18
Mar 2026
Two new studies from investigators at Mass General Brigham challenge a decades-old assumption that the thymus, an organ best known for its role in establishing immune function in childhood, becomes irrelevant in adulthood.
18
Mar 2026
Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed.
18
Mar 2026
Women who enter natural menopause before age 40 face about a 40% higher lifetime risk of developing coronary heart disease than women who experience menopause later, according to a large Northwestern Medicine study that is the first to calculate lifetime heart risk associated with premature menopause.
18
Mar 2026
A prospective analysis of 6,531 adults in the multiethnic MESA cohort found that higher ultraprocessed food intake was associated with a graded increase in incident ASCVD risk, with each additional daily serving linked to about a 5% higher risk. The association was stronger in Black participants, while no significant interaction was seen by sex or income.
18
Mar 2026
Researchers used five prospective cohorts from the US and China to identify circulating gut microbiota-related metabolites linked to future coronary heart disease, then tested the findings through discovery, in silico validation, and targeted quantitative validation. The study ultimately highlighted nine metabolites associated with incident CHD, supporting a potential role for microbial metabolism in heart disease risk while not proving causation
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
